Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 7791-13-1
Product Catalog
93-2735
Cobalt › Cobalt(II) chloride hexahydrate (99.999%-Co) PURATREM| CAS Number: | 7791-13-1 |
| MDL Number: | MFCD00149652 |
| Molecular Formula: | Cl2Co |
| Molecular Weight: | 129.84 (237.93) |
| Chemical Formula: | CoCl2·6H2O |
| Color and Form: | red xtl. |
| Note: |
Physical Characteristics: melting point 86°C, density 1.924
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Cobalt (II) chloride hexahydrate (99.999%-Co) PURATREM |
| Product Number: | 93-2735 |
| CAS Registry Number: | 7791-13-1 |
| Formula: | CoCl2.6H2O |
| EINECS Number: | 231-589-4 |
| Chemical Family: | metal halide |
| Synonym: | Cobaltous chloride, hexahydrate; Cobalt dichloride, hexahydrate |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 7791-13-1 | 100 | 0.02mg/m3 (as Co) | no data |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Harmful if swallowed. Irritating to skin, eyes and respiratory tract. Possible risk of impaired fertility. Limited evidence of a carcinogenic effect. May cause heritable genetic damage. |
| Primary Routes of Exposure: | Skin and eyes, ingestion and dust inhalation. |
| Eye Contact: | Causes irritation, redness, and pain. |
| Skin Contact: | May cause dermatitis. Causes irritation to skin. Symptoms include redness, itching, and pain. |
| Inhalation: | Causes irritation to the respiratory tract, coughing, shortness of breath, nausea, respiratory hypersensitivity, and asthma. |
| Ingestion: | Harmful if swallowed. May cause abdominal pain, nausea, vomiting, mild hypo tension, rash, and ringing in the ears. |
| Acute Health Effects: | Harmful if swallowed. Irritating to skin, eyes and respiratory tract. May cause abdominal pain, nausea, vomiting, coughing and shortness of breath. |
| Chronic Health Effects: | Possible risk of impaired fertility. Limited evidence of a carcinogenic effect. Repeated oral administration may produce goiter and reduced thyroid activity. Chronic exposure associated with kidney, heart and lung damage. May cause heritable genetic damage. |
| NTP: | No |
| IARC: | Yes |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | Material is non-flammable. |
| Special Fire Fighting Procedures: | If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit fumes containing toxic cobalt compounds. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate powder and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store material in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear appropriate chemical resistant gloves and protective clothing. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | In the absence of adequate ventilation a respirator should be worn. The use of a respiratory requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | red xtl. |
| Molecular Weight: | 129.84 (237.93) |
| Melting Point: | 86°C |
| Boiling Point: | no data |
| Vapor Pressure: | not applicable |
| Specific Gravity: | 1.924 |
| Odor: | none |
| Solubility in Water: | 76g/100cc (0°C) |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | active metals |
| Decomposition Products: | Water and cobalt chloride |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Oral (rat); LD50: 766 mg/kg. Administration into the eye (rat); LD50: >2 gm/kg. Intraperitoneal (rat); LD50: 35 mg/kg. Subcutaneous (rat); LDLo: 121 mg/kg. Intraperitoneal (mouse); LD50: 90 mg/kg. Subcutaneous (mouse); LDLo: 100 mg/kg. Intravenous (dog); LDLo: 30300 ug/kg. Subcutaneous (rabbit); LDLo: 200 mg/kg. Intravenous (rabbit); LDLo: 25400 ug/kg. Intravenous (guinea pig); LD50: 26 mg/kg. Oral (mouse); TDLo: 3949 mg/kg. Oral (mouse); TDLo: 182 mg/kg. Intraperitoneal (mouse); TDLo: 1392 mg/kg. Human Lymphocyte; DNA damage: 4500 ug/L. |
| Carcinogenic Effects: | Possible tumorigen |
| Mutagenic Effects: | Mutagen |
| Tetratogenic Effects: | Reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Very toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Not listed in TSCA inventory |
| SARA (Title 313): | Title compound see Category Code N096 for reporting. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 4/08/2001 |
| Revision Date: | 8/16/2011 |
